{"transactions":[{"id":4636444,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T22:06:25.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":10.7504,"value":268760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $10.665 to $10.78 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the \"Issuer\") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2777788,"source":{"system":"sec-edgar","filing":"0001326110-26-000085","document":"wk-form4_1791324382.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611026000085/wk-form4_1791324382.xml","form_type":"4"}},{"id":725467,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-27T01:00:07.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":7.8763,"value":196907.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $7.875 to $7.885 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the \"Issuer\") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2802788,"source":{"system":"sec-edgar","filing":"0001647994-26-000011","document":"wk-form4_1782522004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000011/wk-form4_1782522004.xml","form_type":"4"}},{"id":747916,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:29:40.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":23033,"price":7.1769,"value":165305.5377,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 23,033 shares sold in the price range of $7.125 to $7.225 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the \"Issuer\") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2827788,"source":{"system":"sec-edgar","filing":"0001647994-26-000008","document":"wk-form4_1780694977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000008/wk-form4_1780694977.xml","form_type":"4"}},{"id":879636,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T01:12:26.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":75000,"price":12.0105,"value":900787.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 75,000 shares sold in the price range of $12.00 to $12.025 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the \"Issuer\") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2850821,"source":{"system":"sec-edgar","filing":"0001647994-26-000006","document":"wk-form4_1772154743.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000006/wk-form4_1772154743.xml","form_type":"4"}},{"id":884786,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-02-25T01:03:46.000Z","date":"2026-02-22","kind":"exercise","planned":true,"acquired":false,"shares":15243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."}],"balance_after":15245,"derivative":{"underlying":"Common Stock","underlying_shares":15243},"source":{"system":"sec-edgar","filing":"0001647994-26-000004","document":"wk-form4_1771981423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000004/wk-form4_1771981423.xml","form_type":"4"}},{"id":884785,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T01:03:46.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":165000,"price":10.2491,"value":1691101.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 165,000 shares sold in the price range of $9.89 to $10.635 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2925821,"source":{"system":"sec-edgar","filing":"0001647994-26-000004","document":"wk-form4_1771981423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000004/wk-form4_1771981423.xml","form_type":"4"}},{"id":884784,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T01:03:46.000Z","date":"2026-02-22","kind":"tax_withholding","planned":true,"acquired":false,"shares":6026,"price":8.7,"value":52426.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 22, 2026, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on February 20, 2026 was the settlement price used to calculate the shares withheld."}],"balance_after":3090821,"source":{"system":"sec-edgar","filing":"0001647994-26-000004","document":"wk-form4_1771981423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000004/wk-form4_1771981423.xml","form_type":"4"}},{"id":884783,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T01:03:46.000Z","date":"2026-02-22","kind":"exercise","planned":true,"acquired":true,"shares":15243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."}],"balance_after":3096847,"source":{"system":"sec-edgar","filing":"0001647994-26-000004","document":"wk-form4_1771981423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000004/wk-form4_1771981423.xml","form_type":"4"}},{"id":884782,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T01:03:46.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":9.25,"value":92500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2024."}],"balance_after":3081604,"source":{"system":"sec-edgar","filing":"0001647994-26-000004","document":"wk-form4_1771981423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000004/wk-form4_1771981423.xml","form_type":"4"}},{"id":934205,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-22T01:34:45.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":75000,"price":7.8791,"value":590932.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 75,000 shares sold in the price range of $7.87 to $7.8950 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3091604,"source":{"system":"sec-edgar","filing":"0001647994-26-000002","document":"wk-form4_1769045681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000002/wk-form4_1769045681.xml","form_type":"4"}},{"id":934204,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-22T01:34:45.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":76967,"price":6.54,"value":503364.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2024."}],"balance_after":3166604,"source":{"system":"sec-edgar","filing":"0001647994-26-000002","document":"wk-form4_1769045681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000002/wk-form4_1769045681.xml","form_type":"4"}},{"id":1246145,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-02-26T02:11:06.000Z","date":"2025-02-22","kind":"exercise","planned":false,"acquired":false,"shares":15243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."}],"balance_after":30488,"derivative":{"underlying":"Common Stock","underlying_shares":15243},"source":{"system":"sec-edgar","filing":"0001326110-25-000020","document":"wk-form4_1740535859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611025000020/wk-form4_1740535859.xml","form_type":"4"}},{"id":1246144,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-26T02:11:06.000Z","date":"2025-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":5453,"price":3.42,"value":18649.26,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 22, 2025, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on February 21, 2025 was the settlement price used to calculate the shares withheld."}],"balance_after":3243571,"source":{"system":"sec-edgar","filing":"0001326110-25-000020","document":"wk-form4_1740535859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611025000020/wk-form4_1740535859.xml","form_type":"4"}},{"id":1246143,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-26T02:11:06.000Z","date":"2025-02-22","kind":"exercise","planned":false,"acquired":true,"shares":15243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."}],"balance_after":3249024,"source":{"system":"sec-edgar","filing":"0001326110-25-000020","document":"wk-form4_1740535859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611025000020/wk-form4_1740535859.xml","form_type":"4"}},{"id":1295586,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-25T01:47:52.000Z","date":"2025-01-22","kind":"exercise","planned":false,"acquired":false,"shares":110020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cash exercise of options scheduled to expire on February 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option vested each month on the same day as the vesting commencement date, such that the shares subject to the option became fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option was January 16, 2015."}],"balance_after":0,"derivative":{"exercise_price":1.9984,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":110020},"source":{"system":"sec-edgar","filing":"0001326110-25-000006","document":"wk-form4_1737769665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611025000006/wk-form4_1737769665.xml","form_type":"4"}},{"id":1295585,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-25T01:47:52.000Z","date":"2025-01-22","kind":"exercise","planned":false,"acquired":true,"shares":110020,"price":1.9984,"value":219863.968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cash exercise of options scheduled to expire on February 16, 2025."}],"balance_after":3233781,"source":{"system":"sec-edgar","filing":"0001326110-25-000006","document":"wk-form4_1737769665.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611025000006/wk-form4_1737769665.xml","form_type":"4"}},{"id":1471089,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T19:44:18.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.569,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-076997","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000095017024076997/ownership.xml","form_type":"4"}},{"id":1619386,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-26T21:43:17.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":159146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the option shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the option shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this option is February 22, 2024."}],"balance_after":159146,"derivative":{"exercise_price":5.24,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":159146},"source":{"system":"sec-edgar","filing":"0001326110-24-000028","document":"wk-form4_1708983764.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611024000028/wk-form4_1708983764.xml","form_type":"4"}},{"id":1619385,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-26T21:43:17.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":45731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."}],"balance_after":45731,"derivative":{"underlying":"Common Stock","underlying_shares":45731},"source":{"system":"sec-edgar","filing":"0001326110-24-000028","document":"wk-form4_1708983764.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611024000028/wk-form4_1708983764.xml","form_type":"4"}},{"id":1661702,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-03T00:38:38.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":57200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 57,199 of the RSUs subject to the award vested on September 1, 2023 and 57,200 of the RSUs subject to the award vested on January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 57,199 of the RSUs subject to the award vested on September 1, 2023 and 57,200 of the RSUs subject to the award vested on January 31, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":57200},"source":{"system":"sec-edgar","filing":"0001326110-24-000015","document":"wk-form4_1706920709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611024000015/wk-form4_1706920709.xml","form_type":"4"}},{"id":1661701,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-03T00:38:38.000Z","date":"2024-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":22094,"price":3.36,"value":74235.84,"ownership":{"direct":true},"balance_after":3123761,"source":{"system":"sec-edgar","filing":"0001326110-24-000015","document":"wk-form4_1706920709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611024000015/wk-form4_1706920709.xml","form_type":"4"}},{"id":1661700,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-03T00:38:38.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":57200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3145855,"source":{"system":"sec-edgar","filing":"0001326110-24-000015","document":"wk-form4_1706920709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611024000015/wk-form4_1706920709.xml","form_type":"4"}},{"id":1787138,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-09-06T23:39:01.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":57199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 57,199 of the RSUs subject to the award vested on September 1, 2023 and 57,200 of the RSUs subject to the award shall vest on January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 57,199 of the RSUs subject to the award vested on September 1, 2023 and 57,200 of the RSUs subject to the award shall vest on January 31, 2024."}],"balance_after":57200,"derivative":{"underlying":"Common Stock","underlying_shares":57199},"source":{"system":"sec-edgar","filing":"0001326110-23-000113","document":"wk-form4_1694043530.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611023000113/wk-form4_1694043530.xml","form_type":"4"}},{"id":1787137,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-06T23:39:01.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":57199,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3088655,"source":{"system":"sec-edgar","filing":"0001326110-23-000113","document":"wk-form4_1694043530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611023000113/wk-form4_1694043530.xml","form_type":"4"}},{"id":1795270,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-08-29T01:01:14.000Z","date":"2023-08-25","kind":"grant","planned":false,"acquired":true,"shares":114399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 57,199 of the RSUs subject to the award shall vest on September 1, 2023 and 57,200 of the RSUs subject to the award shall vest on January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 57,199 of the RSUs subject to the award shall vest on September 1, 2023 and 57,200 of the RSUs subject to the award shall vest on January 31, 2024."}],"balance_after":114399,"derivative":{"underlying":"Common Stock","underlying_shares":114399},"source":{"system":"sec-edgar","filing":"0001326110-23-000108","document":"wk-form4_1693270861.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611023000108/wk-form4_1693270861.xml","form_type":"4"}},{"id":1861108,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T18:49:28.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.5,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-036041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919123036041/doc4.xml","form_type":"4"}},{"id":2236547,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T17:16:31.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.24,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-036018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919122036018/doc4.xml","form_type":"4"}},{"id":2317689,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-26T01:05:42.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":10714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the shares subject to the option shall vest in equal annual installments on each of the first, second and third anniversaries of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this option is March 23, 2022."}],"balance_after":10714,"derivative":{"exercise_price":5.83,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":10714},"source":{"system":"sec-edgar","filing":"0001326110-22-000022","document":"wf-form4_164825672604822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611022000022/wf-form4_164825672604822.xml","form_type":"4"}},{"id":2422541,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-28T21:28:59.000Z","date":"2021-06-04","kind":"gift","acquired":false,"shares":71051,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3031456,"source":{"system":"sec-edgar","filing":"0001326110-22-000003","document":"wf-form5_164340529573345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000132611022000003/wf-form5_164340529573345.xml","form_type":"5"}},{"id":2696940,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T00:00:37.000Z","date":"2021-05-25","kind":"sale","acquired":false,"shares":88787,"price":16.1828,"value":1436822.2636,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 88,787 shares sold in the price range of $16.00 to $16.425 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3102507,"source":{"system":"sec-edgar","filing":"0001209191-21-035815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121035815/doc4.xml","form_type":"4"}},{"id":2696939,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T00:00:37.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":21223,"price":16.0237,"value":340070.9851,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 21,223 shares sold in the price range of $16.00 to $16.115 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3191294,"source":{"system":"sec-edgar","filing":"0001209191-21-035815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121035815/doc4.xml","form_type":"4"}},{"id":2696938,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T00:00:37.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":14990,"price":16.0883,"value":241163.617,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 14,990 shares sold in the price range of $16.00 to $16.26 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3212517,"source":{"system":"sec-edgar","filing":"0001209191-21-035815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121035815/doc4.xml","form_type":"4"}},{"id":2723165,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-07T20:09:57.000Z","date":"2021-05-05","kind":"exercise","acquired":false,"shares":56967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is December 18, 2014. The option originally covered 200,000 pre 1.8515 for 1 forward split shares. Pursuant to the reporting person's employment agreement, the shares subject to the option shall be subject to certain accelerated vesting and post-termination exercise period provisions upon certain events."}],"balance_after":0,"derivative":{"exercise_price":1.7544,"expiration_date":"2024-12-18","underlying":"Common Stock","underlying_shares":56967},"source":{"system":"sec-edgar","filing":"0001209191-21-030886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121030886/doc4.xml","form_type":"4"}},{"id":2723164,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-07T20:09:57.000Z","date":"2021-05-05","kind":"exercise","acquired":true,"shares":56967,"price":1.7544,"value":99942.9048,"ownership":{"direct":true},"balance_after":3227507,"source":{"system":"sec-edgar","filing":"0001209191-21-030886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121030886/doc4.xml","form_type":"4"}},{"id":2768371,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-30T20:21:02.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the Shares subject to the Option shall vest on the one (1) month anniversary of March 3, 2021 (the \"Vesting Commencement Date\"), and one thirty-sixth (1/36th) of the Shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider (as defined in the Viracta Therapeutics, Inc. 2021 Equity Incentive Plan) through each such date."}],"balance_after":80000,"derivative":{"exercise_price":8.74,"expiration_date":"2031-03-26","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-21-023661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919121023661/doc4.xml","form_type":"4"}},{"id":2874501,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-08T21:54:30.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":22100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is January 16, 2015."}],"balance_after":110020,"derivative":{"exercise_price":1.9984,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":22100},"source":{"system":"sec-edgar","filing":"0001209191-21-008510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121008510/doc4.xml","form_type":"4"}},{"id":2874500,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2021-02-08T21:54:30.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":22100,"price":23.089,"value":510266.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 22,100 shares sold in the price range of $23.00 to $23.315 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-21-008510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121008510/doc4.xml","form_type":"4"}},{"id":2874499,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2021-02-08T21:54:30.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":22100,"price":1.9984,"value":44164.64,"ownership":{"direct":true},"balance_after":3192640,"source":{"system":"sec-edgar","filing":"0001209191-21-008510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121008510/doc4.xml","form_type":"4"}},{"id":2879216,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-04T23:39:21.000Z","date":"2021-02-02","kind":"exercise","acquired":false,"shares":82070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is January 16, 2015."}],"balance_after":132120,"derivative":{"exercise_price":1.9984,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":82070},"source":{"system":"sec-edgar","filing":"0001209191-21-007873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121007873/doc4.xml","form_type":"4"}},{"id":2879215,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2021-02-04T23:39:21.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":82070,"price":20.6507,"value":1694802.949,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 82,070 shares sold in the price range of $20.50 to $20.98 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-21-007873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121007873/doc4.xml","form_type":"4"}},{"id":2879214,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2021-02-04T23:39:21.000Z","date":"2021-02-02","kind":"exercise","acquired":true,"shares":82070,"price":1.9984,"value":164008.688,"ownership":{"direct":true},"balance_after":3252610,"source":{"system":"sec-edgar","filing":"0001209191-21-007873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121007873/doc4.xml","form_type":"4"}},{"id":2890326,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-30T00:59:34.000Z","date":"2021-01-28","kind":"exercise","acquired":false,"shares":11304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is January 16, 2015."}],"balance_after":214190,"derivative":{"exercise_price":1.9984,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":11304},"source":{"system":"sec-edgar","filing":"0001209191-21-006310","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121006310/doc4.xml","form_type":"4"}},{"id":2890325,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-30T00:59:34.000Z","date":"2021-01-27","kind":"exercise","acquired":false,"shares":36626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is January 16, 2015."}],"balance_after":225494,"derivative":{"exercise_price":1.9984,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":36626},"source":{"system":"sec-edgar","filing":"0001209191-21-006310","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121006310/doc4.xml","form_type":"4"}},{"id":2890324,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2021-01-30T00:59:34.000Z","date":"2021-01-28","kind":"sale","acquired":false,"shares":11304,"price":20.5344,"value":232120.8576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 11,304 shares sold in the price range of $20.50 to $20.75 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-21-006310","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121006310/doc4.xml","form_type":"4"}},{"id":2890323,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2021-01-30T00:59:34.000Z","date":"2021-01-28","kind":"exercise","acquired":true,"shares":11304,"price":1.9984,"value":22589.9136,"ownership":{"direct":true},"balance_after":3181844,"source":{"system":"sec-edgar","filing":"0001209191-21-006310","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121006310/doc4.xml","form_type":"4"}},{"id":2890322,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2021-01-30T00:59:34.000Z","date":"2021-01-27","kind":"sale","acquired":false,"shares":36626,"price":20.6123,"value":754946.0998,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 36,626 shares sold in the price range of $20.50 to $20.78 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-21-006310","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121006310/doc4.xml","form_type":"4"}},{"id":2890321,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2021-01-30T00:59:34.000Z","date":"2021-01-27","kind":"exercise","acquired":true,"shares":36626,"price":1.9984,"value":73193.3984,"ownership":{"direct":true},"balance_after":3207166,"source":{"system":"sec-edgar","filing":"0001209191-21-006310","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919121006310/doc4.xml","form_type":"4"}},{"id":2915768,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-06T21:46:30.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 4, 2021. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":12.36,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-000712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000089924321000712/doc4.xml","form_type":"4"}},{"id":2931318,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-28T23:23:46.000Z","date":"2020-12-22","kind":"exercise","acquired":false,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is January 16, 2015."}],"balance_after":262120,"derivative":{"exercise_price":1.9984,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-20-065246","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120065246/doc4.xml","form_type":"4"}},{"id":2931317,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-12-28T23:23:46.000Z","date":"2020-12-22","kind":"sale","acquired":false,"shares":130000,"price":18.0508,"value":2346604.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 130,000 shares sold in the price range of $18.00 to $18.245 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-20-065246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120065246/doc4.xml","form_type":"4"}},{"id":2931316,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-12-28T23:23:46.000Z","date":"2020-12-22","kind":"exercise","acquired":true,"shares":130000,"price":1.9984,"value":259792.0,"ownership":{"direct":true},"balance_after":3300540,"source":{"system":"sec-edgar","filing":"0001209191-20-065246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120065246/doc4.xml","form_type":"4"}},{"id":3077794,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-22T20:05:09.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":1565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is January 16, 2015."}],"balance_after":392120,"derivative":{"exercise_price":1.9984,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":1565},"source":{"system":"sec-edgar","filing":"0001209191-20-043298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120043298/doc4.xml","form_type":"4"}},{"id":3077793,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-22T20:05:09.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":87705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is January 16, 2015."}],"balance_after":393685,"derivative":{"exercise_price":1.9984,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":87705},"source":{"system":"sec-edgar","filing":"0001209191-20-043298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120043298/doc4.xml","form_type":"4"}},{"id":3077792,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-22T20:05:09.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":40730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is December 18, 2014. The option originally covered 200,000 pre 1.8515 for 1 forward split shares. Pursuant to the reporting person's employment agreement, the shares subject to the option shall be subject to certain accelerated vesting and post-termination exercise period provisions upon certain events."}],"balance_after":56967,"derivative":{"exercise_price":1.7554,"expiration_date":"2024-12-18","underlying":"Common Stock","underlying_shares":40730},"source":{"system":"sec-edgar","filing":"0001209191-20-043298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120043298/doc4.xml","form_type":"4"}},{"id":3077791,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-07-22T20:05:09.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":1565,"price":15.5004,"value":24258.126,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 1,565 shares sold in the price range of $15.50 to $15.5050 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-20-043298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120043298/doc4.xml","form_type":"4"}},{"id":3077790,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-07-22T20:05:09.000Z","date":"2020-07-21","kind":"exercise","acquired":true,"shares":1565,"price":1.9984,"value":3127.496,"ownership":{"direct":true},"balance_after":3172105,"source":{"system":"sec-edgar","filing":"0001209191-20-043298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120043298/doc4.xml","form_type":"4"}},{"id":3077789,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-07-22T20:05:09.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":128435,"price":15.5337,"value":1995070.7595,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 128,435 shares sold in the price range of $15.50 to $15.70 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-20-043298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120043298/doc4.xml","form_type":"4"}},{"id":3077788,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-07-22T20:05:09.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":87705,"price":1.9984,"value":175269.672,"ownership":{"direct":true},"balance_after":3298975,"source":{"system":"sec-edgar","filing":"0001209191-20-043298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120043298/doc4.xml","form_type":"4"}},{"id":3077787,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-07-22T20:05:09.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":40730,"price":1.7554,"value":71497.442,"ownership":{"direct":true},"balance_after":3211270,"source":{"system":"sec-edgar","filing":"0001209191-20-043298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120043298/doc4.xml","form_type":"4"}},{"id":3084952,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-10T21:00:49.000Z","date":"2020-07-08","kind":"exercise","acquired":false,"shares":39950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is December 18, 2014. The option originally covered 200,000 pre 1.8515 for 1 forward split shares. Pursuant to the reporting person's employment agreement, the shares subject to the option shall be subject to certain accelerated vesting and post-termination exercise period provisions upon certain events."}],"balance_after":97697,"derivative":{"exercise_price":1.7554,"expiration_date":"2024-12-18","underlying":"Common Stock","underlying_shares":39950},"source":{"system":"sec-edgar","filing":"0001209191-20-042183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120042183/doc4.xml","form_type":"4"}},{"id":3084951,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-07-10T21:00:49.000Z","date":"2020-07-08","kind":"sale","acquired":false,"shares":39950,"price":13.1354,"value":524759.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 39,950 shares sold in the price range of $13.00 to $13.29 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-20-042183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120042183/doc4.xml","form_type":"4"}},{"id":3084950,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-07-10T21:00:49.000Z","date":"2020-07-08","kind":"exercise","acquired":true,"shares":39950,"price":1.7554,"value":70128.23,"ownership":{"direct":true},"balance_after":3210490,"source":{"system":"sec-edgar","filing":"0001209191-20-042183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120042183/doc4.xml","form_type":"4"}},{"id":3091938,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-02T22:32:46.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":9,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is December 18, 2014. The option originally covered 200,000 pre 1.8515 for 1 forward split shares. Pursuant to the reporting person's employment agreement, the shares subject to the option shall be subject to certain accelerated vesting and post-termination exercise period provisions upon certain events."}],"balance_after":137647,"derivative":{"exercise_price":1.7554,"expiration_date":"2024-12-18","underlying":"Common Stock","underlying_shares":9},"source":{"system":"sec-edgar","filing":"0001209191-20-040651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120040651/doc4.xml","form_type":"4"}},{"id":3091937,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-07-02T22:32:46.000Z","date":"2020-06-30","kind":"sale","acquired":false,"shares":9,"price":13,"value":117.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-20-040651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120040651/doc4.xml","form_type":"4"}},{"id":3091936,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-07-02T22:32:46.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":9,"price":1.7554,"value":15.7986,"ownership":{"direct":true},"balance_after":3170549,"source":{"system":"sec-edgar","filing":"0001209191-20-040651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120040651/doc4.xml","form_type":"4"}},{"id":3101934,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-23","kind":"exercise","acquired":false,"shares":29609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is December 18, 2014. The option originally covered 200,000 pre 1.8515 for 1 forward split shares. Pursuant to the reporting person's employment agreement, the shares subject to the option shall be subject to certain accelerated vesting and post-termination exercise period provisions upon certain events."}],"balance_after":137656,"derivative":{"exercise_price":1.7554,"expiration_date":"2024-12-18","underlying":"Common Stock","underlying_shares":29609},"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3101933,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-22","kind":"exercise","acquired":false,"shares":136729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is December 18, 2014. The option originally covered 200,000 pre 1.8515 for 1 forward split shares. Pursuant to the reporting person's employment agreement, the shares subject to the option shall be subject to certain accelerated vesting and post-termination exercise period provisions upon certain events."}],"balance_after":167265,"derivative":{"exercise_price":1.7554,"expiration_date":"2024-12-18","underlying":"Common Stock","underlying_shares":136729},"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3101932,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-19","kind":"exercise","acquired":false,"shares":9337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is December 18, 2014. The option originally covered 200,000 pre 1.8515 for 1 forward split shares. Pursuant to the reporting person's employment agreement, the shares subject to the option shall be subject to certain accelerated vesting and post-termination exercise period provisions upon certain events."}],"balance_after":303994,"derivative":{"exercise_price":1.7554,"expiration_date":"2024-12-18","underlying":"Common Stock","underlying_shares":9337},"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3101931,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-23","kind":"sale","acquired":false,"shares":29609,"price":13.0073,"value":385133.1457,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average share price of an aggregate total of 29,609 shares sold in the price range of $13.00 to $13.04 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3101930,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-23","kind":"exercise","acquired":true,"shares":29609,"price":1.7554,"value":51975.6386,"ownership":{"direct":true},"balance_after":3200149,"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3101929,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":10432,"price":13.0089,"value":135708.8448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average share price of an aggregate total of 10,432 shares sold in the price range of $13.00 to $13.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3170540,"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3101928,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":80000,"price":10.5458,"value":843664.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 80,000 shares sold in the price range of $10.50 to $10.88 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3180972,"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3101927,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":66263,"price":9.4292,"value":624807.0796,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 66,263 shares sold in the price range of $9.25 to $9.71 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3260972,"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3101926,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-22","kind":"exercise","acquired":true,"shares":136729,"price":1.7554,"value":240014.0866,"ownership":{"direct":true},"balance_after":3327235,"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3101925,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-19","kind":"sale","acquired":false,"shares":13737,"price":9.0003,"value":123637.1211,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 13,737 shares sold in the price range of $9.00 to $9.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3190506,"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3101924,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-06-24T01:45:53.000Z","date":"2020-06-19","kind":"exercise","acquired":true,"shares":9337,"price":1.7554,"value":16390.1698,"ownership":{"direct":true},"balance_after":3204243,"source":{"system":"sec-edgar","filing":"0001209191-20-038679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120038679/doc4.xml","form_type":"4"}},{"id":3130671,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-05-29T20:27:30.000Z","date":"2020-05-27","kind":"sale","acquired":false,"shares":75000,"price":7.5645,"value":567337.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 75,000 shares sold in the price range of $7.50 to $7.645 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3194906,"source":{"system":"sec-edgar","filing":"0001209191-20-032930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120032930/doc4.xml","form_type":"4"}},{"id":3137276,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-05-22T21:37:19.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":36932,"price":5.5155,"value":203698.446,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 36,932 shares sold in the price range of $5.50 to $5.555 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3269906,"source":{"system":"sec-edgar","filing":"0001209191-20-031845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120031845/doc4.xml","form_type":"4"}},{"id":3150920,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2020-05-14T00:04:32.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":28068,"price":5.5048,"value":154508.7264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 28,068 shares sold in the price range of $5.50 to $5.5350 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3306838,"source":{"system":"sec-edgar","filing":"0001209191-20-029014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120029014/doc4.xml","form_type":"4"}},{"id":3318494,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-06T23:02:02.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy."}],"balance_after":9600,"derivative":{"exercise_price":16.31,"exercise_date":"2021-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001209191-20-002066","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919120002066/doc4.xml","form_type":"4"}},{"id":3709134,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-03T23:40:54.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9600,"derivative":{"exercise_price":5.16,"exercise_date":"2020-01-02","expiration_date":"2026-01-02","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001209191-19-001336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919119001336/doc4.xml","form_type":"4"}},{"id":3830580,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-30T01:00:05.000Z","date":"2018-08-27","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the award recipient's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the option shall vest as follows: twenty five percent (25%) of the shares subject to the option shall vest and become exercisable on August 27, 2019, and thereafter the remaining shares subject to the option shall vest and become exercisable in equal monthly installments over thirty six (36) months, such that the option will be fully vested and exercisable on August 27, 2022."}],"balance_after":200000,"derivative":{"exercise_price":3.07,"expiration_date":"2028-08-27","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-048878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919118048878/doc4.xml","form_type":"4"}},{"id":3893991,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-14T21:39:08.000Z","date":"2018-06-12","kind":"exercise","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":14.24,"exercise_date":"2018-12-31","expiration_date":"2025-06-12","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-18-037818","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919118037818/doc4.xml","form_type":"4"}},{"id":4606813,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2016-09-09T22:40:43.000Z","date":"2016-09-08","kind":"sale","acquired":false,"shares":30000,"price":7.4,"value":222000.0,"ownership":{"direct":true},"balance_after":3334906,"source":{"system":"sec-edgar","filing":"0001209191-16-140825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919116140825/doc4.xml","form_type":"4"}},{"id":4606812,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":35137,"kind":"person","name":"Simon Barry J.","position":1,"cik":"0001647994","reported_name":"Simon Barry J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2016-09-09T22:40:43.000Z","date":"2016-09-07","kind":"sale","acquired":false,"shares":2000,"price":8.8356,"value":17671.2,"ownership":{"direct":false,"nature":"By mother-in-law"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 400 shares sold in the price range of $60.00 to $60.01 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21143,"source":{"system":"sec-edgar","filing":"0001209191-16-140825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647994/000120919116140825/doc4.xml","form_type":"4"}}]}